• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 101967-950
Device Problem Communication or Transmission Problem (2896)
Patient Problem Hyperglycemia (1905)
Event Date 04/25/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.The investigation was performed on the user synced glucose data on data management system (dms), which is an eversense cloud platform.Based on the investigation analysis, the system asserted an out of range high glucose alert at 05:28 am (time of incident).There was no sensor readings displayed because of this alert.The alert history also showed multiple high-glucose alerts issued to the user at 2: 03am and 5: 03am, before the reported event at 5:28am.The customer had to call an ambulance but refused to go to the hospital.She received an infusion and was feeling fine.The system performed as intended by asserting high glucose alert at the time of incident.Overall, the system was performing as intended and the customer entered calibrations fit sensor glucose (sg) trends well with the exception of some instances where calibrations were too close or matched exactly with sg value.This behavior suggests that customer sometimes enters sg values itself for calibration instead of entering true fingerstick blood glucose (bg) values.The customer was recommended to enter true finger stick bg values for calibration as anything other than that could result in significant deviations.No further investigation was found necessary for this complaint.
 
Event Description
Senseonics was made aware of an incident where the customer experienced hyperglycemia on (b)(6) 2023.The customer reported that the blood glucose (bg) value was above 400 mg/dl, but the eversense cgm system did not show any glucose values or provided alert.Customer called an ambulance and received an infusion, but did not know which medication.The customer did not go to the hospital and is currently doing fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18117044
MDR Text Key327885609
Report Number3009862700-2023-00226
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date06/08/2023
Device Model Number101967-950
Device Catalogue NumberFG-4500-50-302
Device Lot Number129966
Was Device Available for Evaluation? No
Date Manufacturer Received06/03/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/08/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-